The detected immune activation, highlighted by elevated cytokines (IFN-γ and IL-4) and enhanced CD8 + T cell infiltration, emphasizes this combination therapy’s potential to alter the tumor microenvironment. This evidence concerns the gene IFNG and neoplasm.